Market Cap 4.87M
Revenue (ttm) 4.94M
Net Income (ttm) -8.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -165.18%
Debt to Equity Ratio 0.00
Volume 73,925
Avg Vol 1,142,712
Day's Range N/A - N/A
Shares Out 3.31M
Stochastic %K 69%
Beta 0.96
Analysts Strong Buy
Price Target $45.00

Company Profile

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its pres...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 604 669 7207
Fax: 778 945 6800
Address:
885 West Georgia Street, Suite 1445, Vancouver, Canada
JimmyOcarri
JimmyOcarri Aug. 17 at 8:41 PM
0 · Reply
Ian980
Ian980 Aug. 7 at 11:57 PM
$INM Ultra low float stock. Patience is needed here, could easily go from 1.40 to 1.45…2.10 2.60 2.89
0 · Reply
lisa_anderson
lisa_anderson Aug. 1 at 3:06 PM
$INM ANOTHER @APEDM LOsER PUMPER ALERT
0 · Reply
Ian980
Ian980 Jul. 30 at 10:51 PM
$INM The Daily Cost Is Punishing: A 197% annual fee means short sellers are paying roughly 0.54% of their total position value every single day just to hold the short open.Extreme Squeeze Risk: Because the daily fees drain a short seller's capital so rapidly, any positive headline regarding the Mentari Therapeutics merger filings or their Alzheimer’s disease program (INM-901) could force short sellers to panic-buy shares to exit, triggering a violent upward short squeeze.Micro-Cap Trap: INM is a micro-cap stock with a market value of roughly $6 million to $9 million. Because the "float" (the number of shares available to the public to trade) is incredibly small, even a minor wave of retail buying volume can cause the stock price to spike unpredictably.
0 · Reply
StockTradingManager
StockTradingManager Jul. 27 at 9:29 AM
0 · Reply
Ian980
Ian980 Jul. 27 at 9:24 AM
0 · Reply
Stef_Gee
Stef_Gee Jul. 25 at 1:23 AM
$INM 😏
0 · Reply
Ian980
Ian980 Jul. 24 at 10:09 PM
$INM patience 😉
0 · Reply
StockTradingManager
StockTradingManager Jul. 24 at 8:26 PM
$WBUY $INM $ZCMD after hour 👁️👁️ high interest rate and weekend. Short will pay 💰
0 · Reply
StockTradingManager
StockTradingManager Jul. 24 at 6:46 PM
$WBUY $ZCMD $INM high short interest with low float & no short share available. They are using dark pool short I guess so this high interest nobody like to pay so after hour will be nice play. I am holding small position all of them.
0 · Reply
Latest News on INM
InMed Pharmaceuticals Transcript: M&A announcement

May 19, 2026, 8:30 AM EDT - 3 months ago

InMed Pharmaceuticals Transcript: M&A announcement


InMed Pharmaceuticals Press release: M&A announcement

May 19, 2026, 8:30 AM EDT - 3 months ago

InMed Pharmaceuticals Press release: M&A announcement


InMed Pharmaceuticals Amends Preferred Investment Options

May 19, 2026, 6:00 AM EDT - 3 months ago

InMed Pharmaceuticals Amends Preferred Investment Options


InMed Pharmaceuticals Quarterly report: Q3 2026

May 6, 2026, 7:00 AM EDT - 3 months ago

InMed Pharmaceuticals Quarterly report: Q3 2026


InMed Pharmaceuticals Earnings release: Q3 2026

May 6, 2026, 7:00 AM EDT - 3 months ago

InMed Pharmaceuticals Earnings release: Q3 2026


InMed Pharmaceuticals files $50M mixed securities shelf

2026-03-20T21:05:52.000Z - 5 months ago

InMed Pharmaceuticals files $50M mixed securities shelf


InMed Pharmaceuticals provides development outlook for 2026

2026-03-09T12:01:31.000Z - 5 months ago

InMed Pharmaceuticals provides development outlook for 2026


InMed Pharmaceuticals Earnings release: Q2 2026

Feb 11, 2026, 7:00 AM EST - 6 months ago

InMed Pharmaceuticals Earnings release: Q2 2026


InMed Pharmaceuticals Quarterly report: Q2 2026

Feb 11, 2026, 7:00 AM EST - 6 months ago

InMed Pharmaceuticals Quarterly report: Q2 2026


InMed Provides Update on BayMedica Commercial Business

Dec 12, 2025, 5:31 PM EST - 8 months ago

InMed Provides Update on BayMedica Commercial Business


InMed Pharmaceuticals Earnings release: Q1 2026

Nov 6, 2025, 4:00 PM EST - 10 months ago

InMed Pharmaceuticals Earnings release: Q1 2026


InMed Pharmaceuticals Quarterly report: Q1 2026

Nov 6, 2025, 4:00 PM EST - 10 months ago

InMed Pharmaceuticals Quarterly report: Q1 2026


InMed Pharmaceuticals Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 10 months ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 10 months ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 10 months ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Earnings release: Q4 2025

Sep 23, 2025, 7:00 AM EDT - 11 months ago

InMed Pharmaceuticals Earnings release: Q4 2025


InMed Pharmaceuticals Annual report: Q4 2025

Sep 23, 2025, 7:00 AM EDT - 11 months ago

InMed Pharmaceuticals Annual report: Q4 2025


InMed Pharmaceuticals announces $5M private placement

2025-06-25T12:15:44.000Z - 1 year ago

InMed Pharmaceuticals announces $5M private placement


InMed Pharmaceuticals Proxy statement: Proxy Filing

May 29, 2025, 8:00 AM EDT - 1 year ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Earnings release: Q3 2025

May 11, 2025, 6:00 PM EDT - 1 year ago

InMed Pharmaceuticals Earnings release: Q3 2025


InMed Pharmaceuticals Quarterly report: Q3 2025

May 11, 2025, 6:00 PM EDT - 1 year ago

InMed Pharmaceuticals Quarterly report: Q3 2025


InMed Pharmaceuticals Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Quarterly report: Q2 2025

Feb 13, 2025, 4:00 PM EST - 1 year ago

InMed Pharmaceuticals Quarterly report: Q2 2025


InMed Announces Results of 2024 Annual General Meeting

Dec 18, 2024, 8:00 PM EST - 1 year ago

InMed Announces Results of 2024 Annual General Meeting


InMed Enters Into Standby Equity Purchase Agreement

Dec 17, 2024, 4:56 PM EST - 1 year ago

InMed Enters Into Standby Equity Purchase Agreement


InMed Pharmaceuticals Quarterly report: Q1 2025

Nov 14, 2024, 9:30 AM EST - 1 year ago

InMed Pharmaceuticals Quarterly report: Q1 2025


InMed Pharmaceuticals Transcript: Status Update

Nov 12, 2024, 2:00 PM EST - 1 year ago

InMed Pharmaceuticals Transcript: Status Update


InMed Pharmaceuticals Slides: Status Update

Nov 12, 2024, 2:00 PM EST - 1 year ago

InMed Pharmaceuticals Slides: Status Update


InMed Pharmaceuticals Proxy statement: Proxy Filing

Oct 28, 2024, 8:00 AM EDT - 1 year ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Proxy statement: Proxy Filing

Oct 28, 2024, 8:00 AM EDT - 1 year ago

InMed Pharmaceuticals Proxy statement: Proxy Filing


InMed Pharmaceuticals Earnings release: Q4 2024

Sep 30, 2024, 6:00 AM EDT - 2 years ago

InMed Pharmaceuticals Earnings release: Q4 2024


InMed Pharmaceuticals Annual report: Q4 2024

Sep 30, 2024, 6:00 AM EDT - 2 years ago

InMed Pharmaceuticals Annual report: Q4 2024


InMed Pharmaceuticals Transcript: Emerging Growth Conference 72

Jun 13, 2024, 1:45 PM EDT - 2 years ago

InMed Pharmaceuticals Transcript: Emerging Growth Conference 72


InMed to Present at the Emerging Growth Conference

Jun 10, 2024, 5:18 PM EDT - 2 years ago

InMed to Present at the Emerging Growth Conference


InMed Pharmaceuticals Quarterly report: Q3 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

InMed Pharmaceuticals Quarterly report: Q3 2024


JimmyOcarri
JimmyOcarri Aug. 17 at 8:41 PM
0 · Reply
Ian980
Ian980 Aug. 7 at 11:57 PM
$INM Ultra low float stock. Patience is needed here, could easily go from 1.40 to 1.45…2.10 2.60 2.89
0 · Reply
lisa_anderson
lisa_anderson Aug. 1 at 3:06 PM
$INM ANOTHER @APEDM LOsER PUMPER ALERT
0 · Reply
Ian980
Ian980 Jul. 30 at 10:51 PM
$INM The Daily Cost Is Punishing: A 197% annual fee means short sellers are paying roughly 0.54% of their total position value every single day just to hold the short open.Extreme Squeeze Risk: Because the daily fees drain a short seller's capital so rapidly, any positive headline regarding the Mentari Therapeutics merger filings or their Alzheimer’s disease program (INM-901) could force short sellers to panic-buy shares to exit, triggering a violent upward short squeeze.Micro-Cap Trap: INM is a micro-cap stock with a market value of roughly $6 million to $9 million. Because the "float" (the number of shares available to the public to trade) is incredibly small, even a minor wave of retail buying volume can cause the stock price to spike unpredictably.
0 · Reply
StockTradingManager
StockTradingManager Jul. 27 at 9:29 AM
0 · Reply
Ian980
Ian980 Jul. 27 at 9:24 AM
0 · Reply
Stef_Gee
Stef_Gee Jul. 25 at 1:23 AM
$INM 😏
0 · Reply
Ian980
Ian980 Jul. 24 at 10:09 PM
$INM patience 😉
0 · Reply
StockTradingManager
StockTradingManager Jul. 24 at 8:26 PM
$WBUY $INM $ZCMD after hour 👁️👁️ high interest rate and weekend. Short will pay 💰
0 · Reply
StockTradingManager
StockTradingManager Jul. 24 at 6:46 PM
$WBUY $ZCMD $INM high short interest with low float & no short share available. They are using dark pool short I guess so this high interest nobody like to pay so after hour will be nice play. I am holding small position all of them.
0 · Reply
rks1970
rks1970 Jul. 24 at 4:57 PM
$INM Not many shares left to short are there?
0 · Reply
Xpotrad
Xpotrad Jul. 24 at 4:42 PM
$INM one trader just bought 19K shares $1.87, doubt they did that just for the fun of it, the manipulator creeps that shorted this below two bucks, better stay on their toes.
0 · Reply
Xpotrad
Xpotrad Jul. 24 at 4:35 PM
$INM buyside pressures have been building up for the past hour, fools stacking the offer, hopefully theyre shorters that get blown up over two bucks.
0 · Reply
StockTradingManager
StockTradingManager Jul. 24 at 3:35 PM
$INM are we going up or what ? need volume
1 · Reply
_MarginOfSanity_
_MarginOfSanity_ Jul. 24 at 2:25 PM
$NVVE $CJMB $INM in $ADVB waiting did lower entry.
1 · Reply
Muh002
Muh002 Jul. 24 at 8:32 AM
$INM today another pump
0 · Reply
topstockalerts
topstockalerts Jul. 23 at 8:05 PM
$INM what looked like noise is starting to look intentional.
0 · Reply
StockTradingManager
StockTradingManager Jul. 23 at 7:07 PM
$ZYBT sold comeback when I see opportunity now buying $INM again
0 · Reply
History101
History101 Jul. 23 at 5:33 PM
$INM 6,316 watching 7/23/2026
0 · Reply
Xpotrad
Xpotrad Jul. 23 at 5:24 PM
$INM could be setting up to retake two bucks, and if it was to, and stay above that key level, perhaps makes a run at $2.30.
1 · Reply
Ian980
Ian980 Jul. 23 at 4:39 PM
0 · Reply